Print Header
www.ccsa.ca

Drug-impaired Driving

​Driving under the influence of alcohol and other drugs remains the most prominent factor contributing to serious collisions in Canada. While the devastating consequences of alcohol-impaired driving are well known, the harm of driving under the influence of drugs is gaining more attention. The percentage of Canadians drivers fatally injured in vehicle crashes and testing positive for drugs now exceeds that of drivers testing positive for alcohol.​

Cannabis and driving

Cannabis and Driving: Questions and Answers for Policymaking is the result of a recent collaboration between CCSA and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The policy brief overviews current knowledge about driving under the influence of cannabis and the latest developments in its regulation. It addresses the tough questions that policy makers must ask when formulating policy around this continually evolving issue.

Addressing drug-impaired driving

There is one set of penalties for all impaired driving, whether from drugs or alcohol. Drug-impaired drivers can be detected by police officers who are trained and certified as Drug Recognition Experts. Such experts evaluate a driver’s behaviour and can request a blood, urine or oral fluid sample for testing. Read our policy brief on oral fluid drug screening​.​

The Drug Evaluation and Classification (DEC) program is a 12-step systematic, standardized procedure authorized for use in Canada to evaluate suspected drug-impaired drivers. The DEC protocol provides a valid, reliable evaluation of impairment as a result of drug use. Read our policy brief on the DEC program.

“Per se” laws for alcohol establish a legal limit for blood alcohol content. If a driver has more than the per se limit of blood alcohol, then the driver is judged to be impaired. Per se limits for drugs should be considered, although this is more challenging as the limits need to be agreed upon for each drug, including prescription drugs. Read our policy brief on per se limits for drugs​.

Psychoactive prescription drugs can also contribute to impaired driving. Although the ways in which drugs affect the body and brain vary, the effects will have the same overall result: a decrease in the brain’s ability to process information and respond by movement, skills relevant for driving. This decrease has negative effects on driving ability and increases the risk of a car crash. Read our report on The Effects of Psychoactive Prescription Drugs on Driving.

International Symposium on Drugs and Driving

The first International Symposium on Drugs and Driving was held in Montreal in 2011, with CCSA hosting in partnership with the U.S. Office of National Drug Control Policy, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the U.S. National Institute on Drug Abuse (NIDA). CCSA was also a partner for the second symposium, held in 2014 in New Zealand, and the third symposium, held in 2017 in Lisbon. (Reports and presentations from the second and third symposia are available at the links provided.)